COLUMN GROUP II, LP
CIK 1600420 · last filed 2024-12-23
COLUMN GROUP II, LP is a corporate insider who has filed 9 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for RAPT, was dated Dec 23, 2024. Across all open-market trades the lifetime net is +$409.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $33.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$33.71M
3
9
$409.02M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. (RAPT) Delisted | 10%+ Owner | 1,286,261 | $58.01 | $74.62M | $67.50M | 4 | 2024-12-23 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | 10%+ Owner | 205,000 | $1.54 | $315.7K | $341.52M | 3 | 2020-08-25 |
| NRIX | 10%+ Owner | 1,989,000 | $16.95 | $33.71M | $0 | 1 | 2020-07-29 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-23 | RAPT Therapeutics, Inc. (RAPT) Delisted | Other (J) | −29,514,250 | $0 | EDGAR |
| 2024-12-23 | RAPT Therapeutics, Inc. (RAPT) Delisted | Other (J) | −14,757,125 | $0 | EDGAR |
| 2021-08-20 | RAPT Therapeutics, Inc. (RAPT) Delisted | Other (J) | −11,523,180 | $0 | EDGAR |
| 2020-08-25 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +184,450 | $3.31M | EDGAR |
| 2020-07-29 | NRIX | Conv (C) | +66,725,480 | $0 | EDGAR |
| 2020-03-25 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +3,011,800 | $35.81M | EDGAR |
| 2019-11-04 | RAPT Therapeutics, Inc. (RAPT) Delisted | Mixed | +60,544,359 | $67.50M | EDGAR |
| 2019-04-10 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Mixed | +149,831,340 | $302.40M | EDGAR |
| 2017-10-30 | — | Buy (P) | +21,448,000 | $87.94M |